Lydia L Wu

Ms. Lydia L Wu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
NANatalia Antonides-Jensen
Natalia Antonides-Jensen
MSMuskan Singh
Muskan Singh
YXYuqing Xue
Yuqing Xue
FFFernando Flores-Guzman
Fernando Flores-Guzman
LWLydia L Wu
Lydia L Wu
SHSonia L Hernandez
Sonia L Hernandez
Background: High-risk neuroblastoma (NB) is a pediatric malignancy associated with metastases and an immunosuppressive tumor microenvironment. Standard-of-care treatments like chemotherapy are often ineffective, which motivates the investigation of adjuvant approaches. Histotripsy is a noninvasive focused ultrasound therapy that ablates tissue through the mechanical action of bubble clouds. In addition to disruption of the targeted tumor, non-targeted lesions may exhibit growth delay after the histotripsy procedure. The primary hypothesis of this study was histotripsy-induced shifts in the tumor microenvironment will improve the response of metastatic NB to chemotherapy. Methods: Female A/J mice flanks were inoculated bilaterally with 1 × 106 Neuro-2a cells. Histotripsy was applied to one tumor (200–500 mm3), with or without concurrent administration of liposomal doxorubicin (LDOX). The contralateral tumor served as a model of non-targeted distal metastases. Following treatment, tumors were monitored indefinitely for growth, or assessed after 5–7 days with flow cytometry, single-cell RNA sequencing, and immunohistochemistry. Results: Histotripsy alone delayed the growth of treated and contralateral tumors relative to controls (p = 0.01 and p < 0.0001, respectively) and increased CD8+ T and CD11b+ cells (p < 0.05 for both comparisons). Further, NB cells in targeted and contralateral tumors exhibited a decrease in c-Myc expression and cell-cycle activity, and upregulation of interferon and apoptosis pathways. Histotripsy combined with LDOX had the longest delay in tumor growth (p < 0.0001 vs. untreated controls; p < 0.001 vs. other arms) and greatest expression of CD8+ and MOMA staining. Conclusions: These findings indicate that histotripsy induces a systemic antitumor immune response that potentiates chemotherapy efficacy in this model of metastatic NB.